dihydroalprenolol has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burdsall, J; Hollinger, B; Neely, J; Whitsett, JA; Workman, L | 1 |
| Rodan, GA; Rodan, SB | 1 |
2 other study(ies) available for dihydroalprenolol and Osteogenic Sarcoma
| Article | Year |
|---|---|
beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Bone Neoplasms; Cell Line; Child; Dihydroalprenolol; Ethanolamines; Humans; Metoprolol; Mice; Mice, Nude; Neuroblastoma; Osteosarcoma; Receptors, Adrenergic, beta; Sarcoma, Ewing | 1983 |
Dexamethasone effects on beta-adrenergic receptors and adenylate cyclase regulatory proteins Gs and Gi in ROS 17/2.8 cells.
Topics: Adenosine Diphosphate Ribose; Adenylyl Cyclases; Animals; Cell Line; Cholera Toxin; Cyclic AMP; Cycloheximide; Dexamethasone; Dihydroalprenolol; Enzyme Activation; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Isoproterenol; Kinetics; Molecular Weight; NAD; Osteosarcoma; Rats; Receptors, Adrenergic, beta | 1986 |